Thermo Fisher Scientific (TMO) Free Cash Flow (2009 - 2026)

Thermo Fisher Scientific has reported Free Cash Flow for 18 years, with the latest figure at $1.7 billion in Q2 2026.

• Free Cash Flow for Q2 2026 came in at $1.7 billion, up 51.58% year-over-year; the trailing twelve-month figure through Jun 2026 was $7.3 billion (up 18.61% YoY), and the FY2025 annual result was $6.3 billion, down 13.4% from the prior year.
• Free Cash Flow grew to $1.7 billion in Q2 2026, from $816.0 million in the prior quarter.
• Over five years, Free Cash Flow peaked at $3.3 billion in Q4 2023 and troughed at $271.0 million in Q2 2023.
• A 5-year average of $1.7 billion and a median of $1.6 billion in 2022 frame the typical range for Free Cash Flow.
• The widest annual swing landed in 2023, when Free Cash Flow sank 82.65%; it then soared 233.58% in 2024.
• A 5-year view of Free Cash Flow shows it stood at $2.9 billion in 2022, then climbed by 12.97% to $3.3 billion in 2023, then decreased by 15.31% to $2.8 billion in 2024, then increased by 6.48% to $3.0 billion in 2025, then tumbled by 44.02% to $1.7 billion in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were $1.7 billion in Q2 2026, $816.0 million in Q1 2026, and $3.0 billion in Q4 2025.